MedTrace Logo

An Initial Investigation Into the Effects of β-Alanine on Performance and Physiological Responses During Simulated Wrestling Matches

NCT07641907 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-06-11

No results posted yet for this study

Summary

This research aims to investigate the effects of beta-alanine (BA) supplementation on simulated 2-day freestyle wrestling performance, as well as on exercise-induced muscle fatigue and oxidative stress in wrestlers. In addition to the common issue of long-term insufficient energy intake due to weight control, high-intensity training can further exacerbate exercise-induced oxidative stress and muscle fatigue, thereby impairing athletic performance. Therefore, finding effective ergogenic aids to reduce these negative physiological responses is crucial for optimizing athletes' competitive condition. Based on a literature review, this study will implement the Specific Wrestling Performance Test (SWPT) to simulate two consecutive days of freestyle wrestling competitions according to Kraemer's model. Multiple performance assessments will be used to evaluate the impact of BA supplementation on athletes' physiological indicators and performance. It is expected that BA supplementation will enhance systemic antioxidant capacity, reduce muscle fatigue and oxidative stress induced by simulated wrestling matches, and improve wrestling-specific physical performance.

Conditions

  • Healthy
  • Athletes

Interventions

OTHER

Placebo (Placebo trial)

The Placebo capsule supplement was taken for 4 weeks (6 capsules per day).

OTHER

Beta-Alanine (Beta-Alanine trial)

The Beta-Alanine capsule supplement was taken for 4 weeks, with a daily dosage of 4.8 g of Beta-Alanine (equivalent to 6 capsules per day, each containing 800 mg of Beta-Alanine).

Sponsors & Collaborators

  • China Medical University, Taiwan

    collaborator OTHER

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Jung-Piao Tsao · China Medical University, China

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
12 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-11
Primary Completion
2026-05-24
Completion
2026-10-01

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07641907 on ClinicalTrials.gov